medline.ch Onkologie Gynäkologische Tumoren

	Predictive value of node-RADS scoring system for axillary lymph node metastasis in breast cancer. BMC Med Imaging Çubuk HS, Erkent M, Ya, Y. PMID: 41606527 [PubMed - as supplied by publisher]
	TBKBP1 induces capecitabine resistance through negative regulation of type I interferon pathway in triple-negative breast cancer. Oncogene Wu WY, Yang YS, Andriani L, Xie YF, Di GH, Shao ZM, Li JJ. PMID: 41606294 [PubMed - as supplied by publisher]
	Breast cancer survivors' perspectives on a clinical decision tool to support individualized exercise prescriptions and discussions. Support Care Cancer Wilson OWA, Wojcik KM, Kerr EM, Rivera I, Tian E, Schneider JD, Brick R, Berrigan D, Tamura K, Rogers LQ, Demark-Wahnefried W, Street RL Jr, Jayasekera J. PMID: 41606253 [PubMed - indexed for MEDLINE]
	Incidence, risk factors, and outcomes of ovarian metastasis in early-stage cervical cancer: a population-based analysis of 983 patients. Arch Gynecol Obstet Gennari P, Luft D, Mészáros J, Ignatov A. PMID: 41606252 [PubMed - indexed for MEDLINE]
	Assessing ethnic inequalities in diagnostic intervals of breast cancer among patients presenting symptoms to general practitioners in England. Sci Rep Martins T, Lavu D, Hamilton W, Abel G, Neal RD. PMID: 41606009 [PubMed - as supplied by publisher]
	Implementation of the Hugo Robotic System: Early Outcomes and Learning Curves in Hysterectomy by Surgeons With and Without Prior Robotic Experience. Asian J Endosc Surg Komatsu H, Wada I, Yamamoto K, Hiratsuka Y, Hikino K, Okawa M, Iida Y, Nagata H, Sawada M, Sato S, Taniguchi F. PMID: 41605858 [PubMed - indexed for MEDLINE]
	Evaluating the effectiveness and acceptability of free door-to-door transport to increase the uptake of breast screening appointments in Yorkshire: a cluster randomised GP feasibility trial (DOORSTEP protocol). BMJ Open Haji Sadeghi M, Cohen J, Bamidele O, Roberts H, Williams B, Acaster B, Miles H, Huang C, Pitel L, Dawkins B, Abass W, Peacock L, Macleod U, Kelly C. PMID: 41605588 [PubMed - indexed for MEDLINE]
	Diagnostic tests for ovarian cancer in premenopausal women with non-specific symptoms (ROCkeTS): prospective, multicentre, cohort study. BMJ Sundar S, Agarwal R, Scandrett K, Davenport C, Van Calster B, Johnson S, Sengupta P, Selvi-Vikram R, Kwong FL, Mallett S, Rick C, Kehoe S, Timmerman D, Bourne T, Stobart H, Neal RD, Menon U, Gentry-Maharaj A, Sturdy L, Ottridge R, Deeks JJ, ROCkeTS collaborators. PMID: 41605528 [PubMed - indexed for MEDLINE]
	Associations of Lipid Metabolism Abnormalities and Obesity With Endometriosis-Associated Ovarian Cancer. J Obstet Gynaecol Res Asano F, Momomura M, Shibuya H, Matsumoto H, Morisada T, Kobayashi Y. PMID: 41605467 [PubMed - indexed for MEDLINE]
	Current Status of Fertility-Sparing Treatment for Gynecological Cancers in Japan: A Nationwide Survey. J Obstet Gynaecol Res Shikama A, Nishio H, Okugawa K, Kajiyama H, Suzuki N, Fujiwara H, Watari H, Komatsu H, Yamagami W, Satoh T, Kawana K, Kato K. PMID: 41605464 [PubMed - indexed for MEDLINE]
	Impact of Power Morcellation and Histopathological Subtypes on the Development of Peritoneal Leiomyomatosis Following Laparoscopic Myomectomy. J Obstet Gynaecol Res , Durda, Ya, Ayd, , Çelik H. PMID: 41605457 [PubMed - indexed for MEDLINE]
	Proteomic Studies That Predict Patients' Responses to High-Grade Serous Ovarian Cancer Treatments: A Systematic Review. J Proteome Res Scanlan J, Mittal P, Oehler MK, Hoffmann P, Hoffmann MK. PMID: 41605417 [PubMed - as supplied by publisher]
	The role and prospects of the Fudan classification in precision medicine for triple-negative breast cancer. Cancer Genet Yang Q, Li B, Chen Y, Yang H. PMID: 41604874 [PubMed - as supplied by publisher]
	Clinical management of common toxicities with inhibitors targeting the PI3K/AKT/mTOR pathway in breast cancer. ESMO Open Jhaveri KL, Iyengar NM, Turner NC, Rugo HS, O'Shaughnessy J, Barrios CH, Curigliano G, André F, Im SA, Goncalves MD, Lacouture ME, Fasching PA, Leung R. PMID: 41604817 [PubMed - as supplied by publisher]
	Associations of individual and combined alterations in essential trace metal levels with breast cancer risk: A case-control study in Tanzania. J Trace Elem Med Biol Njale E, Mahugija JAM, Shilla DJ, Mbare NS. PMID: 41604780 [PubMed - as supplied by publisher]
	Palbociclib for Hormone-Receptor-Positive, HER2-Positive Advanced Breast Cancer. N Engl J Med Metzger O, Mandrekar S, Goel S, Gligorov J, Lim E, Ciruelos E, Loibl S, Dockter T, Gonzàlez Farré X, Francis PA, Lynce F, Lanzillotti J, DuFrane C, Wall A, Strand C, Krop I, Vaz-Luis I, Tripathy D, Loi S, Prat A, Goetz M, Escrivá-de-Romaní S, Porter D, Spoenlein J, Stover DG, Sardesai S, Heudel P, Koehler M, Huang Bartlett C, Holynskyj A, Gopalakrishna P, Gauthier E, Delaloge S, Miller K, Winer EP, Gianni L, Partridge AH, DeMichele A, Carey LA. PMID: 41604639 [PubMed - indexed for MEDLINE]
	Dairy consumption and breast cancer risk: A comprehensive systematic review of current evidence. Nutr Health Naowaset P. PMID: 41604531 [PubMed - as supplied by publisher]
	Comparative Performance of Visual Inspection with Acetic Acid and Colposcopy for Detection of Cervical Precancer in Women with High-Risk Human Papillomavirus Infection: A Cross-Sectional Study. Cancer Control Kuljarusnont S, Karnchanabanyong W, Ruengkhachorn I, Ularnwong M, Ittiamornlert P, Hanamornroongruang S. PMID: 41604310 [PubMed - indexed for MEDLINE]
	Family-Centered Advance Care Planning in Patients With Breast Cancer: A Randomized Controlled Trial in China. Omega (Westport) Wang R, Gao R, Pei S, Zhang C, Li D, Shen Y. PMID: 41604160 [PubMed - as supplied by publisher]
	MicroRNA-mediated modulation of cancer-associated fibroblasts in HER2-positive breast tumor microenvironment: a comprehensive review. Discov Oncol Ardah MT, Abdulsahib WK, Naji HA, Jyothi SR, Sahoo S, Janney JB, Sharma V, Sinha A, Kholiyeva M. PMID: 41604098 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 323554

Seite 1 von 16178

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung